MettlerToledo International (MTD)
(Delayed Data from NYSE)
$1,420.36 USD
-22.30 (-1.55%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $1,420.67 +0.31 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1,420.36 USD
-22.30 (-1.55%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $1,420.67 +0.31 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Zacks News
Bruker (BRKR) Up 6.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mettler-Toledo (MTD) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Industry Outlook Mettler-Toledo and Bruker
by Zacks Equity Research
Mettler-Toledo and Bruker have been highlighted in this Industry Outlook article.
2 Instruments Stocks to Watch From a Prospering Industry
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like MTD and BRKR are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.
Why Mettler-Toledo (MTD) International Revenue Trends Deserve Your Attention
by Zacks Equity Research
Examine the evolution of Mettler-Toledo's (MTD) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Here's What Key Metrics Tell Us About Mettler-Toledo (MTD) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Mettler-Toledo (MTD) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Mettler-Toledo (MTD) Q2 Earnings Top Estimates, Sales Fall Y/Y
by Zacks Equity Research
Mettler-Toledo's (MTD) second-quarter results benefit from strength in the Laboratory segment. However, sluggish market demand in China acts as a headwind.
Mettler-Toledo (MTD) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 7.22% and 2.48%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Mettler-Toledo's (MTD) Q2 Earnings?
by Zacks Equity Research
Mettler-Toledo's (MTD) second-quarter results are likely to reflect weak momentum across the Industrial, Laboratory and Food Retail segments.
Countdown to Mettler-Toledo (MTD) Q2 Earnings: Wall Street Forecasts for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Mettler-Toledo (MTD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
Earnings Preview: Mettler-Toledo (MTD) Q2 Earnings Expected to Decline
by Zacks Equity Research
Mettler-Toledo (MTD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Beat the Market Like Zacks: Goldman Sachs, Micron, Amgen in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Here's Why Mettler-Toledo (MTD) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Beat the Market the Zacks Way: EverQuote, Micron, Amgen in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Zacks Industry Outlook Highlights Mettler-Toledo and Bruker
by Zacks Equity Research
Mettler-Toledo and Bruker have been highlighted in this Industry Outlook article.
2 Instruments Stocks to Watch From a Prospering Industry
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.
Don't Overlook Mettler-Toledo (MTD) International Revenue Trends While Assessing the Stock
by Zacks Equity Research
Explore how Mettler-Toledo's (MTD) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Beat the Market the Zacks Way: Micron, Freshpet, Colgate-Palmolive in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Mettler-Toledo (MTD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Mettler-Toledo (MTD) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Mettler-Toledo (MTD) Q1 Earnings Top Estimates, Sales Fall Y/Y
by Zacks Equity Research
Mettler-Toledo's (MTD) first-quarter 2024 results reflect the impacts of weak momentum in the Food Retail segment and challenging market conditions in China.
Mettler-Toledo (MTD) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 16.82% and 5.14%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Harvard Bioscience (HBIO) Q1 Earnings Match Estimates
by Zacks Equity Research
Harvard Bioscience (HBIO) delivered earnings and revenue surprises of 0% and 4.92%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Mettler-Toledo's (MTD) Q1 Earnings?
by Zacks Equity Research
Mettler-Toledo's (MTD) first-quarter performance is likely to reflect the adverse impacts of macroeconomic headwinds, and weak momentum across the Industrial and Laboratory segments.
Exploring Analyst Estimates for Mettler-Toledo (MTD) Q1 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Mettler-Toledo (MTD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
Analysts Estimate Mettler-Toledo (MTD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Mettler-Toledo (MTD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.